Literature DB >> 1352127

Analysis of J beta gene segment usage by CD4+ and CD8+ human peripheral blood T lymphocytes.

J Grunewald1, M Jeddi-Tehrani, E Pisa, C H Janson, R Andersson, H Wigzell.   

Abstract

Certain T cell antigen receptor V gene products in man have been shown by us and others to display a reproducible bias for preferential expression in CD4+ or CD8+ T cell subsets. In order to investigate whether such a skewed representation of V gene segments is also present at the J gene segment level, we tested the relative J beta gene usage by V beta 5.1 + T cells, as this V beta gene is biased towards CD4+ T cell expression in virtually all individuals. To analyze the usage of the 13 J beta gene segments, we developed a new approach using V beta 5.1 and C beta specific oligonucleotides as 5' and 3' primers respectively for polymerase chain reaction (PCR) amplification of cDNA derived from CD4+ or CD8+ peripheral blood lymphocyte (PBL) T cells. The PCR products were visualized for reactivity with individual J beta 1.1-1.6 and J beta 2.1-2.7 32P-labelled oligonucleotide probes using autoradiography and quantitative gel-scanning. Eleven normal blood donors provided the PBL T cells. The results showed that in every individual's V beta 5.1+ T cell populations (CD4 and CD8), all V beta/J beta combinations were used although at varying but reproducible levels for each J beta gene. Thus, no discernible disallowance of combinations existed. Moreover, we could show that six of 13 J beta genes were unequally expressed when compared in pairs with regard to expression in CD4+ and CD8+ T cell subsets.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352127     DOI: 10.1093/intimm/4.6.643

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

1.  Overexpression of select T cell receptor V beta gene families within CD4+ and CD8+ T cell subsets of myasthenia gravis patients: a role for superantigen(s)?

Authors:  D Gigliotti; A K Lefvert; M Jeddi-Tehrani; S Esin; V Hodara; R Pirskanen; H Wigzell; R Andersson
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

2.  Sequence analysis of the human alpha beta T-cell receptor CDR3 region.

Authors:  P A Moss; J I Bell
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  Usage of TCRAV and TCRBV gene families in human fetal and adult TCR rearrangements.

Authors:  F M Raaphorst; J van Bergen; R L van den Bergh; M van der Keur; R de Krijger; J Bruining; M J van Tol; J M Vossen; P J van den Elsen
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

4.  Genetic control of T cell receptor BJ gene expression in peripheral lymphocytes of normal and rheumatoid arthritis monozygotic twins.

Authors:  T Nanki; H Kohsaka; N Mizushima; W E Ollier; D A Carson; N Miyasaka
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

5.  Restricted usage of T cell receptor V alpha/J alpha gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patients.

Authors:  J Grunewald; T Hultman; A Bucht; A Eklund; H Wigzell
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

6.  Restricted T cell receptor V-beta and J-beta usage in T cells from interleukin-2-cultured lymphocytes of ovarian and renal carcinomas.

Authors:  E Halapi; Y Yamamoto; C Juhlin; M Jeddi-Tehrani; J Grunewald; R Andersson; C Hising; G Masucci; H Mellstedt; R Kiessling
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

7.  Preferential usage of T-cell receptor V beta 17 by dengue virus-specific human T lymphocytes in a donor with immunity to dengue virus type 4.

Authors:  Y Okamoto; S J Gagnon; I Kurane; A M Leporati; F A Ennis
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome.

Authors:  F Rieux-Laucat; P Bahadoran; N Brousse; F Selz; A Fischer; F Le Deist; J P De Villartay
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

9.  Mycoplasma superantigen is a CDR3-dependent ligand for the T cell antigen receptor.

Authors:  A S Hodtsev; Y Choi; E Spanopoulou; D N Posnett
Journal:  J Exp Med       Date:  1998-02-02       Impact factor: 14.307

10.  Somatic Variation of T-Cell Receptor Genes Strongly Associate with HLA Class Restriction.

Authors:  Paul L Klarenbeek; Marieke E Doorenspleet; Rebecca E E Esveldt; Barbera D C van Schaik; Neubury Lardy; Antoine H C van Kampen; Paul P Tak; Robert M Plenge; Frank Baas; Paul I W de Bakker; Niek de Vries
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.